Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2023

Inventory Disclosure [Abstract]

Summary of Inventory

Inventory consisted of the following as of the periods presented (in thousands):

	December 31, 2023		December 31, 2022
Raw materials	$	19,338	$	13,486
Work-in-process	12,680		21,950
Finished goods	19,379		7,716
Total inventory	$	51,397	$	43,152

Summary of Property and Equipment

Depreciation is computed using the straight-line method over the following estimated useful lives:

Assets	Estimated Useful Life
Leasehold improvements	12 years
Furniture, fixtures, equipment and software	3 - 7 years

Property and equipment consisted of the following as of the periods presented (in thousands):

	December 31, 2023		December 31, 2022
Finance lease right-of-use assets	$	78,599	$	—
Leasehold improvements	24,874		20,095
Furniture, fixtures, and equipment	48,793		35,907
Software	3,211		3,004
Total	155,477		59,006
Less accumulated depreciation	(32,214)		(19,502)
Total	123,263		39,504
Construction in-progress	39,637		13,190
Total property and equipment, net	$	162,900	$	52,694

Summary of Other Assets

Other assets consisted of the following as of the periods presented (in thousands):

	December 31, 2023		December 31, 2022
Operating lease right-of-use assets	$	59,746	$	63,896
Interest rate cap	8,559		11,362
Indemnification asset (see Note 2)	6,388		7,682
Prepaid lease payments	—		27,253
Other	2,929		5,396
Total other assets	$	77,622	$	115,589

Summary of Accrued Expenses And Other Current Liabilities

Accrued expenses consisted of the following as of the periods presented (in thousands):

	December 31, 2023		December 31, 2022
Accrued MyChem Retention Payments, current portion (see Note 2)	$	19,446	$	—
Employee related	12,905		19,873
Accrued interest payable	9,202		7,700
Operating lease liabilities, current portion	6,780		6,269
Accrued restructuring costs (see Note 3)	2,814		—
Professional services	2,277		4,093
Customer deposits	2,156		1,665
Sales and use tax liability	1,001		1,029
Inventory holdback liability	—		10,000
Other	3,656		2,742
Total accrued expenses and other current liabilities	$	60,237	$	53,371

Summary of Other Noncurrent Liabilities

Other long-term liabilities consisted of the following as of the periods presented (in thousands):

	December 31, 2023		December 31, 2022
Operating lease liabilities, non-current	$	47,510	$	51,556
Acquisition related tax liability (see Note 2)	6,388		7,682
Accrued Alphayzme Retention Payments, non-current (see Note 2)	3,202		—
Contingent consideration, non-current	1,872		—
Accrued MyChem Retention Payments, non-current (see Note 2)	—		9,324
Other	522		413
Total other long-term liabilities	$	59,494	$	68,975